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HCV co-infection seemed to have no influence
over the CD4 cell decline or plasma HIV viral load
in HIV-infected patients undergoing HAART
interruption. On the other hand, the reported
benefit of HGV co-infection, probably caused by
HIV and HGV competitive replication, which may
influence the lower plasma HIV viral load and the
higher CD4 cell count found in patients receiving
HAART [6], was not found during treatment
discontinuation. This latter finding has to be
treatedwith caution, since the populations studied
were not balanced (six and 16 patients, respect-
ively), and larger studies are desirable.
In summary, neither HCV (including genotype
1) nor HGV co-infection had any influence on
CD4 cell count decline or plasma HIV viral load
rebound in HIV-infected patients undergoing
HAART interruption. However, larger numbers
of patients should be analysed to confirm these
results.
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ABSTRACT
Rapid, accurate and inexpensive methods are
essential to detect drug-resistant Mycobacterium
tuberculosis and allow timely application of effect-
ive treatment and precautions to prevent trans-
mission. The proportion method, the MTT and
Alamar Blue redox methods, and the D29 myco-
bacteriophage assay, were compared for their
ability to detect resistance to isoniazid and rif-
ampicin. When tested against a panel of known
M. tuberculosis strains, the redox methods and the
D29 assay showed good sensitivity and specificity
compared to the proportion method, suggesting
that they could be useful alternatives for identi-
fying multidrug resistance in M. tuberculosis.
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Resistance to anti-tuberculosis drugs is becoming
ubiquitous [1,2]. Rapid and accurate detection is
essential for controlling the spread of drug-resist-
ant strains of Mycobacterium tuberculosis, but
among the conventional methods for drug sus-
ceptibility testing, the proportion method is too
slow, and automated systems are expensive [3–5].
Several molecular methods for the rapid detection
of drug resistance have been described [6–8], but
cost implications have precluded their routine
implementation in tuberculosis-endemic coun-
tries, creating an urgent need for simple, rapid
and inexpensive methods. Two promising alter-
native techniques are colourimetric assays, which
use oxidation–reduction indicators (redox meth-
ods), and the mycobacteriophage assay [9–15]. In
the present study, two redox indicators, Alamar
Blue and 3-(4,5-dimethylthiazol-2-yl)-diphenyl-
tetrazolium bromide (MTT), were tested against
an in-house D29 phage assay for their ability to
detect resistance to isoniazid and rifampicin in
M. tuberculosis.
The study was performed with a panel of 18
coded M. tuberculosis strains with known drug
susceptibility patterns. Isoniazid and rifampicin
were prepared at concentrations of 1 mg ⁄mL in
distilled water and 10 mg ⁄mL in dimethylsulph-
oxide, filter-sterilised, and kept frozen at ) 20C
until use. To prepare the inoculum, a loopful
(10 lL) of bacterial growth on Lo¨wenstein–Jensen
medium was placed in a vial with 3 mL of 7H9
broth and about ten 1-mm glass beads. The vial
was vortexed until a fairly turbid suspension was
obtained, and then left to stand for 15 min to
minimise the possibility of aerosols. The super-
natant was then transferred to a second tube and
7H9 broth was added until the turbidity was
equal to a 1· McFarland standard. The resulting
suspension was diluted 1:20 with 7H9 broth and
used for inoculation. The redox assays were
performed in microtitre plates as described pre-
viously [16–18], with drug concentrations of 0.03–
1.0 mg ⁄L for isoniazid and 0.06–2.0 mg ⁄L for
rifampicin. After incubation for 5 days at 37C,
25 lL of Alamar Blue or 10 lL of MTT solution
were added to each well. Following a further
overnight incubation at 37C, the plates were
assessed for colour development. The breakpoint
drug concentrations defining resistance were
isoniazid 0.2 mg ⁄L and rifampicin 0.5 mg ⁄L.
For the D29 mycobacteriophage assay, high-
titre lysates of the phage were prepared as
described previously [12] and diluted with 7H9-
RSS broth (5 g albumin, 2 g glucose, 0.85 g NaCl
and 100 mL H2O) containing 1 mM CaCl2 to a
working titre of 107 PFU ⁄mL. The final drug
concentrations in the plates were rifampicin
5 mg ⁄L and isoniazid 1.0 mg ⁄L. For the assay,
75-lL aliquots of M. tuberculosis suspension were
added to the wells of microtitre plates containing
75 lL of 7H9-RSS CaCl2 with rifampicin or isoni-
azid. After incubation for 48 h at 37C, 50 lL of
D29 suspension were added to each well, and the
plates were incubated at 37C for 90 min. Extra-
cellular phages were inactivated with 100 lL of
30 mM ferrous ammonium sulphate. To deter-
mine drug resistance, 10 lL of the incubation
mixture was spotted on to Luria–Bertani indicator
plates. Phage plaques were observed after over-
night incubation at 37C and compared with
uninoculated negative controls. Positive controls
without antibiotics, and negative controls without
phage, were also included. The strains were
considered drug-resistant if lytic plaques
appeared on the indicator plates, with none seen
on the negative controls. The proportion method
was used as a standard method for comparison
purposes and was performed according to stand-
ard procedures [3].
The results obtained for the 18 coded strains
with the proportion method and with Alamar
Blue were 100% concordant with those deter-
Table 1. Resistance profile of 18 coded strains of Myco-
bacterium tuberculosis, as determined by four different
susceptibility testing methods
Strain no.
MTT Alamar Blue D29 assay
Proportion
method
INH RMP INH RMP INH RMP INH RMP
001 S S S S S S S S
002 R S R S R S R S
003 R S R S S S R S
004 R R R R R R R R
005 R R R R R R R R
006 R R R R R S R R
007 R R R R R R R R
008 S S S S S S S S
009 R S R S R S R S
010 R R R R R R R R
011 S S S S S S S S
012 S R S R S R S R
013 R S R S R S R S
014 S R S R S R S R
015 R S R S R S R S
016 R R S R R R S R
017 S S S S S S S S
018 S S S S S S S S
R, resistant; S, sensitive; INH, isoniazid; RMP, rifampicin, MTT, 3-(4,5-dimethyl-
thiazol-2-yl)-diphenyltetrazolium bromide.
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mined by the reference laboratory that distributed
the strain panel. The level of agreement between
the two redox methods, as determined by the
kappa test, was 0.886 for isoniazid and 1.0 for
rifampicin. Compared with the proportion meth-
od, all three alternative methods showed good
specificity and sensitivity (Table 1). One strain
(no. 16), was isoniazid-sensitive according to the
proportion method and the Alamar Blue assay,
but was resistant according to the D29 phage
assay and the MTT assay. Another strain (no. 3)
was isoniazid-sensitive only by the D29 phage
assay. Sensitivity and specificity in detecting
isoniazid resistance were thus 100% and 88%,
respectively, with the MTT assay, and 90% and
88%, respectively, with the D29 phage assay.
Of the eight strains found to be rifampicin-
resistant by the redox and proportion methods
(100% sensitivity and specificity), the D29 phage
assay identified seven as resistant and one (no. 6)
as susceptible. The D29 phage assay thus showed
sensitivity and specificity of 87.5% and 100%,
respectively, for detecting rifampicin resistance.
The final concentration of rifampicin in the D29
phage assay was 5.0 mg ⁄L. It is possible that a
reduction in the rifampicin concentration used in
the phage assay to 2.0 mg ⁄L would have enabled
detection of resistance in the one false-negative
strain, but such a reduction would also increase
the risk of false-positive results.
The redox methods can determine resistance
within 7 days, with the advantage of providing
MICs. Alamar Blue is relatively expensive, but
equivalent results can be obtained using the
chemical resazurin, which reduces the cost of this
method to c. US $3 (2.5 Euros) ⁄ strain tested [19].
The D29 phage assay shows good sensitivity and
specificity for detecting resistance to isoniazid and
rifampicin within only 3 days, is relatively easy to
perform and interpret, and is quite inexpensive
(US $1; 0.8 Euros). The phage assay could be
implemented in clinical laboratories as an initial
screening procedure for detecting resistance to
isoniazid and rifampicin. Strains showing resist-
ance in the phage assay could then be tested with
redox methods for a second-level evaluation of the
full susceptibility profile.
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ABSTRACT
Measures to alleviate the growing problem of
macrolide resistance in Taiwan resulted in a
decrease in macrolide consumption, from 0.629
defined daily doses ⁄ 1000 inhabitants per day
(DIDs) in 1999 to 0.301 DIDs in 2003 (a reduction
of 52%). A linear relationship was observed
between the decline in erythromycin con-
sumption and the decline in erythromycin resist-
ance in Streptococcus pyogenes (46% in 1999 vs.
17% in 2003; p < 0.001) and azithromycin resis-
tance in Haemophilus influenzae (31% in 2000 vs.
0% in 2003; p < 0.001). However, the rate of
erythromycin resistance in Streptococcus pneumo-
niae showed a continued increase, from 80.2% in
1999 to 92% in 2003.
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Taiwan has one of the highest levels of antimi-
crobial resistance in the world [1]. In particular,
the resistance of respiratory pathogens (Strepto-
coccus pyogenes, Streptococcus pneumoniae and
Haemophilus influenzae) to macrolides is of great
concern, since several guidelines recommend
macrolides as drugs of choice for community-
acquired respiratory tract infections caused by
these organisms. Prior to 2000, rates of macrolide
resistance in S. pneumoniae (80–90%) and S. pyo-
genes (40–70%), and of azithromycin resistance in
H. influenzae (30–50%), were remarkably high
[1–3]. A number of measures were taken to
alleviate this growing problem, including rigor-
ous enforcement of prescription completion in
pharmacies, and educational programmes for
physicians that focused on appropriate antibiotic
use. In addition, a restrictive governmental policy
was implemented in 2001 to deny reimbursement
through the National Health Insurance system for
the costs of antibiotics used for the treatment of
acute upper respiratory tract infections without
evidence of bacterial involvement [4].
To assess the relationship between macrolide
consumption and macrolide resistance in the
three pathogens mentioned above, data concern-
ing the annual consumption of macrolides (ex-
pressed as defined daily doses ⁄ 1000 inhabitants
per day; DIDs) obtained from IMS Health (Inter-
continental Marketing Service, Taipei, Taiwan)
were evaluated [4]. Pooled disk-diffusion sus-
ceptibility data concerning erythromycin resist-
ance in 3677 isolates of S. pneumoniae (collected
between 1999 and 2003) and 1170 S. pyogenes
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